UK markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
55.04+0.86 (+1.59%)
At close: 04:00PM EDT
56.00 +0.96 (+1.74%)
After hours: 05:48PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.54B
Enterprise value 6.06B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.51
Price/book (mrq)17.36
Enterprise value/revenue 14.85
Enterprise value/EBITDA -12.08

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3-45.24%
S&P500 52-week change 3-4.45%
52-week high 3133.82
52-week low 327.65
50-day moving average 345.73
200-day moving average 367.53

Share statistics

Avg vol (3-month) 31.24M
Avg vol (10-day) 31.21M
Shares outstanding 5102.22M
Implied shares outstanding 6N/A
Float 891.58M
% held by insiders 14.71%
% held by institutions 197.42%
Shares short (28 Jul 2022) 44.22M
Short ratio (28 Jul 2022) 44.4
Short % of float (28 Jul 2022) 45.59%
Short % of shares outstanding (28 Jul 2022) 44.13%
Shares short (prior month 29 Jun 2022) 44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin -135.03%
Operating margin (ttm)-111.78%

Management effectiveness

Return on assets (ttm)-13.76%
Return on equity (ttm)-91.29%

Income statement

Revenue (ttm)408.13M
Revenue per share (ttm)4.01
Quarterly revenue growth (yoy)18.50%
Gross profit (ttm)250.74M
EBITDA -428.6M
Net income avi to common (ttm)-551.1M
Diluted EPS (ttm)-4.13
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)853.69M
Total cash per share (mrq)8.35
Total debt (mrq)1.38B
Total debt/equity (mrq)431.52
Current ratio (mrq)6.18
Book value per share (mrq)3.12

Cash flow statement

Operating cash flow (ttm)-270.69M
Levered free cash flow (ttm)-323.89M